Bridgepoint Group (LON:BPT - Get Free Report)'s stock had its "overweight" rating restated by JPMorgan Chase & Co. in a report issued on Friday,London Stock Exchange reports.
Separately, Citigroup raised Bridgepoint Group to a "buy" rating and set a GBX 410 ($5.60) target price on the stock in a report on Thursday, March 20th.
Check Out Our Latest Analysis on Bridgepoint Group
Bridgepoint Group Stock Performance
BPT traded up GBX 9.67 ($0.13) on Friday, hitting GBX 320.67 ($4.38). 1,079,023 shares of the company traded hands, compared to its average volume of 2,071,556. Bridgepoint Group has a 12-month low of GBX 229.20 ($3.13) and a 12-month high of GBX 410 ($5.60). The company has a 50 day moving average of GBX 288.26 and a 200-day moving average of GBX 319.62. The company has a quick ratio of 3.60, a current ratio of 4.98 and a debt-to-equity ratio of 12.89. The stock has a market capitalization of £2.65 billion, a PE ratio of 58.25, a PEG ratio of 0.61 and a beta of 1.72.
About Bridgepoint Group
(
Get Free Report)
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Further Reading
Before you consider Bridgepoint Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bridgepoint Group wasn't on the list.
While Bridgepoint Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
